Brief: Samsung Engineering Says Receives Letter of Intent from Samsung Biologics For Building Project Worth $689 Mln
21/10/2020 10:02
Oct 21 (Reuters) -
* SAMSUNG ENGINEERING SAYS RECEIVES LETTER OF INTENT FROM
SAMSUNG
BIOLOGICS FOR BUILDING PROJECT WORTH 780 BLN WON($688.52
million)
Source text for Eikon: https://bit.ly/3kkwLG5
Further company coverage: 028050.KS
($1 = 1,132.8600 won)
((Heekyong.Yang@thomsonreuters.com;))
Recent news on Samsung E&A
See all newsBrief: Samsung E&A Co To Acquire 780 Billion Won Worth Of Own Shares
Brief: Samsung E&A Co To Cancel Repurchased Shares Worth 690 Billion Won
South Korea says ordered to pay Elliott $48.49 million over Samsung merger case (updated)
Brief: Samsung E&A Wins 2.49 Trillion Won Order
Analysis: Samsung, SK Hynix payouts test South Korea's reform drive as investors seek more